Clinical Therapeutics/Volume 35, Number 11, 2013

Correction

In the article by D.L. Weinstein et al, titled “A Randomized, Double-Blind Study of Fenofibric Acid Plus RosuvastatinCompared With Rosuvastatin Alone in Stage 3 Chronic Kidney Disease,” (Clin Ther. 2013;35:1186–1198),the sentence “Dr. Weinstein has received research support from AbbVie; Dr. Williams, Dr. Carlson, Dr. Kelly,Ms. Burns, Ms. Setze, Ms. Lele, and Dr. Stolzenbach are employees of and shareholders in AbbVie” should have read“Dr. Weinstein has received research support from AbbVie; Dr. Williams, Dr. Carlson, Dr. Kelly, Ms. Burns,Ms. Setze, Mr. Lele, and Dr. Stolzenbach are employees of and shareholders in AbbVie.”

The corrections mentioned in this erratum have already been made to the article online.

http://dx.doi.org/10.1016/j.clinthera.2013.09.011

1862 Volume 35 Number 11